The reliability of HBV core antibody in serological screening for hepatitis B virus
暂无分享,去创建一个
P. Robertson | W. Rawlinson | William D Rawlinson | Fatma Ba Alawi | Peter W Robertson | Amelia K LePage | Jude Jayamaha | Cristina Baleriola | C. Baleriola | F. Ba Alawi | Jude Jayamaha | A. Lepage | J. Jayamaha | Cristina Baleriola | Fatma Ba Alawi
[1] W. Jilg,et al. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. , 2000, The Journal of general virology.
[2] I. Jacobson,et al. Modern diagnosis of HBV infection , 2009 .
[3] A. Burroughs,et al. Liver grafts from anti-hepatitis B core positive donors: a systematic review. , 2010, Journal of hepatology.
[4] R. Hasz,et al. Nucleic Acid Testing (NAT) of Organ Donors: Is the ‘Best’ Test the Right Test? A Consensus Conference Report , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] S. Günther,et al. Naturally occurring variants of hepatitis B virus. , 1999, Advances in virus research.
[6] T. Sallam,et al. The significance of 'anti-HBc only' in the clinical virology laboratory. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[7] M. Buendia,et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. , 2008, Journal of hepatology.
[8] S. Bowden,et al. Stability of Hepatitis C Virus, HIV, and Hepatitis B Virus Nucleic Acids in Plasma Samples after Long-Term Storage at −20oC and −70oC , 2011, Journal of Clinical Microbiology.
[9] R. Avery,et al. Screening of Donor and Recipient Prior to Solid Organ Transplantation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[10] W. Rawlinson,et al. Infectious disease screening of blood specimens collected post-mortem provides comparable results to pre-mortem specimens , 2011, Cell and Tissue Banking.
[11] M. Schmidt,et al. Sensitivity and specificity of Anti‐HBc screening assays – which assay is best for blood donor screening? , 2009, International journal of laboratory hematology.
[12] J. Allain,et al. Occult hepatitis B virus infection: implications in transfusion , 2004, Vox sanguinis.
[13] M. Ison,et al. Organ donor screening using parallel nucleic acid testing allows assessment of transmission risk and assay results in real time , 2012, Transplant infectious disease : an official journal of the Transplantation Society.
[14] T. Aw,et al. Comparison of the technical and clinical performance of the Elecsys® HBsAg II assay with the Architect®, AxSym®, and Advia® Centaur HBsAg screening assays , 2010, Journal of medical virology.
[15] D. Monos,et al. Changes in the methodology of pre‐heart transplant human leukocyte antibody assessment: an analysis of the United Network for Organ Sharing database , 2015, Clinical transplantation.
[16] P. Holland,et al. Hepatitis B virus blood screening: unfinished agendas , 2006, Vox sanguinis.
[17] M. Petric,et al. The laboratory diagnosis of hepatitis B virus. , 2005, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.
[18] J. Levitsky,et al. Viral Hepatitis in Solid Organ Transplant Recipients , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[19] T. Bauer,et al. A novel deletion mutant of hepatitis B virus surface antigen , 1999, Journal of medical virology.
[20] A. Zuckerman,et al. Mutations of the surface protein of hepatitis B virus. , 2003, Antiviral research.
[21] D. Krüger,et al. Tissue donation and virus safety: more nucleic acid amplification testing is needed , 2010, Transplant infectious disease : an official journal of the Transplantation Society.
[22] G. McCaughan,et al. Long‐term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface‐antigen negative liver transplant recipients from hepatitis B core‐antibody‐positive donors , 2006, Clinical transplantation.
[23] J. Levitt,et al. Impact of Hepatitis B Core Antibody Positive Donors in Lung and Heart-Lung Transplantation: An Analysis of the United Network for Organ Sharing Database , 2009, Transplantation.
[24] E. Vila,et al. Donor screening for hepatitis B virus infection in a cell and tissue bank , 2008, Transplant infectious disease : an official journal of the Transplantation Society.
[25] S. Glynn,et al. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti‐HBc: implications for future HBV screening policy , 2004, Transfusion.
[26] M. Buti,et al. Role of hepatitis B, C, and D viruses in dual and triple infection: Influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference , 2001, Hepatology.
[27] R. Dodd. Current Safety of the Blood Supply in the United States , 2004, International journal of hematology.
[28] K. Lankarani,et al. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. , 2006, The Indian journal of medical research.
[29] F. Hollinger,et al. Occult hepatitis B virus infection: a covert operation , 2010, Journal of viral hepatitis.
[30] J. Aittoniemi,et al. From Abbott ARCHITECT anti-HBc to Anti-HBc II--improved performance in detecting antibodies to hepatitis B core antigen. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[31] H. Margolis,et al. Serological pattern “anti‐HBc alone”: Report on a workshop , 2000, Journal of medical virology.
[32] J. Pawlotsky,et al. Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors. , 2008, Gastroenterology.
[33] E. Seifried,et al. NAT for HBV and anti‐HBc testing increase blood safety , 2002, Transfusion.
[34] L. Mimms,et al. Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. , 1993, BMJ.
[35] J. Emond,et al. The Risk Of Transmission Of Hepatitis B From Hbsag(-), Hbcab(+), Hbigm(-) Organ Donors , 1995, Transplantation.